Global Oral Solid Dosage Pharmaceutical Formulation Market By Product Type (Tablets, Capsules, Powders and Granules, Lozenges and Pastilles, Others) By Drug Release Mechanism (Immediate Release, Delayed Release, Modified Release) By Type (Generic, Branded) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario,Trends and Forecast 2025-2034
- Published date: Nov 2025
- Report ID: 166806
- Number of Pages: 214
- Format:
-
keyboard_arrow_up
-
-
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca plc
- Takeda Pharmaceutical Company Limited
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- Aspen Pharmacare Holdings Ltd.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Gilead Sciences
- AbbVie Inc.
- Boehringer Ingelheim GmbH
- F. Hoffman-La-Roche Ltd.
- Johnson and Johnson
- GSK plc.
- Sun Pharmaceutical Industries Ltd
Our Clients
- 166806
- Nov 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
